I was diagnosed a month ago with Stage 4 (one lymph and one sit bone met) and a 50g prostate tumor with Gleason 9. PSA was 32.5 on Nov 6 (17.2 in May). Got a 30 day shot for ADT on the same day. Then the two mets were treated with 5 sessions of SBRT about 2 weeks ago.
PSA today is 3.2 after a month of ADT and the SBRT.
I would like to get the prostate removed and get triplet treatment afterwards, because RP first seems like a good way to reduce the total PC load and so slow spread (or is that a misconception?)
But maybe that surgery would mean putting off triplet therapy until healed from the surgery (and I don't know how long that might be...4-6 weeks?)
My question is, what order is best in others' opinions?
RP then triplet, or triplet then RP?
And the PC Newsletter says: "Both the TITAN trial of Erleada (apalutamide) and the ENZAMET trial of Xtandi (enzalutamide) showed no benefit for the advanced hormone therapy when docetaxel had been used previously. Timing is important! When chemo or advanced hormone therapy is used as monotherapy, protective mechanisms (like cellular senescence) kick in soon afterward. It protects the cancer cells from destruction by the other medicine. They have to be used together or wait until the first drug stops working."
I'm on ADT, and expect to continue, but my MO is planning to give me another ADT injection + darolutamide.
So the take-way from the newsletter is with the drugs it's "all or nothing"?
Surely, someone has sliced and diced the data with those who had an RP and triple treatment before or after?
But I'd like to hear from others about the conceptual underpinning to the order
Thanks in advance.....